![Peter Damsbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Damsbo
Technik-/Wissenschafts-/F&E-Leiter bei
Coegin Pharma AS
Profil
Peter Damsbo is currently the Chief Medical Officer at Coegin Pharma.
AS since 2010 and a Partner at Ventac Partners GmbH since 2009.
He previously worked as the Medical Director-Diabetes at Novo Nordisk A from 2011 to 2012, and at Novo Nordisk, Inc. as a Medical Director-Diabetes.
He also served as the Chief Medical Officer at Zealand Pharma A and as a Research Fellow at Steno Diabetes Center A. Dr. Damsbo holds a doctorate degree from the University of Copenhagen.
Aktive Positionen von Peter Damsbo
| Unternehmen | Position | Beginn |
|---|---|---|
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Develops inflammatory diseases therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 06.04.2010 |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Corporate Officer/Principal | 01.06.2009 |
Ehemalige bekannte Positionen von Peter Damsbo
| Unternehmen | Position | Ende |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Steno Diabetes Center A/S
 Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter Damsbo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Develops inflammatory diseases therapeutics | Health Technology |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Offers life sciences consultancy services | Commercial Services |
Steno Diabetes Center A/S
Steno Diabetes Center A/S Miscellaneous Commercial ServicesCommercial Services Provides diabetes research laboratory services | Commercial Services |
